Marinus Pharmaceuticals (MRNS) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

MRNS is expected to report earnings to fall 28.67% to -44 cents per share on November 05

Marinus Pharmaceuticals MRNS Stock Earnings Reports

Q3'24

Est.

$-0.45

Q2'24

Missed

by $0.04

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.12

Q3'23

Beat

by $0.05

The last earnings report on August 13 showed earnings per share of -62 cents, missing the estimate of -58 cents. With 572.70K shares outstanding, the current market capitalization sits at 101.35M.

View a ticker or compare two or three

Compare

MRNS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MRNS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

100 Matsonford Road

Phone

+1 484 801-4670

Employees

165

Web

https://www.marinuspharma.com